Back

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study

2024-03-02 oncology Title + abstract only
View on medRxiv
Show abstract

IntroductionThe association of body composition with checkpoint inhibitor outcomes in melanoma is a matter of ongoing debate. In this study, we aim to add to previous evidence by investigating body mass index (BMI) alongside CT derived body composition metrics in the largest cohort to date. MethodPatients treated with first-line anti-PD1 {+/-} anti-CTLA4 for advanced melanoma were retrospectively identified from 11 melanoma reference centers in The Netherlands. Age, sex, Eastern Cooperative Onc...

Predicted journal destinations